Analysis of results declared on 22nd July 2020

Analysis of results declared on 22nd July 2020

Analysis of results declared on 22nd July 2020 #excelgiri

This data is only for education, plz use your own discretion

Astec Lifescience QoQ weak
Sales up 45% but down 38% QoQ
EBIDTA at 28 cr vs 6 cr (last qt it was 43 cr)
PAT at 16 cr vs loss of 1 cr yoy, but down form 31 cr last qtr
Valuations rich at 33x

Sales up 41%, PAT up 70%
Brokerage segment income at 355 cr vs 219 cr
Brokerage segment EBIT at 246 cr vs 164 cr
Retail broking segment continues to report highest record numbers supported by strong industry retail broking volumes
TTM P/E 31x

Rallis India
Revenue up 6%, ebitda up 36%, margins at 19.4% vs 15.1%, pat up 53%
2% margins in march 2019, -3% in march 2020 and now 19% in June 2020 (such is volatility in earnings)
Ttm p/e 29x

Dhanuka Agritech
Sales up 71%, ebidta up 229%, pat up 252%
Ttm p/e 23x, roce 23%
Best ever quarterly performance
Volume growth of 73% YoY (2) launched two products in 1QFY21; set to launch 4 more products in FY21E
Maintains guidance for 20%+ revenue growth with margins improvement of +100bps YoY in FY21

Alembic Pharma
Sales up 41%, EBIDTA up 81%, PAT up 143%
TTM P/E 18.5x, RoCE 22.8%

Heidelberg Cem.
Cement volumes in 1QFY21 declined by 32% YoY to 0.86MT
Realization up 2% QoQ/YoY growth
Sales down 31%, ebidta down 30%, PAT down 38%
Ttm p/e 15x

Everest Ind
Sales down 27%, ebidta down 4%, PAT down 15% (QoQ growth has improved -ebidta this time 39 cr vs 1 cr last qtr vs 40 cr yoy)
Ttm p/e 25x

Finance cost at 505 cr vs sales of 371 cr (ex-other income)
FY20 loss at 4695 cr
Negative net worth of 13582 cr Vs 9727 cr
M-cap is 622 cr

TTK Healthcare
Sales down 2%, ebidta down 72%, pat at 42 lakh vs 5 cr
2% margins vs 7% margins
50x TTM P/E

Music Broadcast
Sales down 80%, ebidta loss at 15 cr vs ebidta profit at 22 cr
TTM P/E 20x

Wanbury (stock up from 11 to 33)
Sales down 34%, ebidta loss at 8 cr vs profit of 7 cr

Varinder Bansal

Managing Partner, Pantomath Asset Management. Ex-Corporate Editor & Head of Research, CNBC-TV18

Leave a Reply

Close Menu